For instance, someone with atrial fibrillation requiring anticoagulation may also be prescribed Wegovy for obesity management
If you're on a stable metformin or semaglutide dose and introduce KLOW at standard research doses (500mcg1mg), you may need to reduce your existing medication dose by 2550% to avoid pushing glucose levels too low
Limited long-term safety data, potential risks such as thyroid tumors and pancreatitis, high costs, and accessibility challenges, particularly in resource-constrained settings, can limit usage
Semaglutide commonly causes nausea, constipation, or mild diarrhea during the dose escalation phase, especially in the first 4-8 weeks
However, some sources indicate that the benzyl alcohol may degrade IGF-1 LR3 structure over time, potentially reducing potency within days to weeks
However, when used as a long-term strategy, it often fails to resolve underlying drivers of painand may introduce new problems over time